Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-09-26
1990-08-28
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514316, 514328, 546233, 546234, 546244, 546189, 546208, C07D21130, C07D40100
Patent
active
049525743
ABSTRACT:
Certain 2,5-disubstituted N-(2-piperidylmethyl)benzamides, wherein one substituent is 2,2,2-trifluoroethyoxy, and pharmaceutically acceptable acid-addition salts thereof, are active as antiarrhythmic agents.
REFERENCES:
patent: 3342826 (1967-09-01), Miller et al.
patent: 3900481 (1975-08-01), Banitt et al.
patent: 4071524 (1978-01-01), Banitt
patent: 4097481 (1978-06-01), Banitt et al.
patent: 4339587 (1982-07-01), Banitt
patent: 4452983 (1984-06-01), Johnson et al.
patent: 4558573 (1985-11-01), Bronn
patent: 4599434 (1986-07-01), Banitt
patent: 4650873 (1987-03-01), Leir
patent: 4656285 (1987-04-01), Bronn
J. Med. Chem. 1977, 20, 821 (Banitt, et al.).
Ford John M.
Kirn Walter N.
Riker Laboratories Inc.
Scalzo Catherine
Sell Donald M.
LandOfFree
Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrhythmic substituted N-(2-piperidylmethyl)benzamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589980